Bigul

Standalone And Consolidated Audited Financial Statements Of The Company For The Quarter And Financial Year Ended 31St March, 2018

The Board of Directors at its meeting held today i.e. 30th May, 2018, has, inter alia: 1. approved the Standalone and Consolidated Audited Financial Statements of the Company for the quarter and financial year ended 31st March, 2018. 2. recommended a final dividend of Rs. 7/- per equity share of Rs. 2/- each for FY ended 31st March, 2018, for the approval of the shareholders of the Company at the ensuing AGM....
30-05-2018
Bigul

Board Meeting-Outcome of Board Meeting

The Board of Directors at its meeting held today i.e. 30th May, 2018, has, inter alia: 1. approved the Standalone and Consolidated Audited Financial Statements of the Company for the quarter and financial year ended 31st March, 2018. 2. recommended a final dividend of Rs. 7/- per equity share of Rs. 2/- each for FY ended 31st March, 2018, for the approval of the shareholders of the Company at the ensuing AGM....
30-05-2018
Bigul

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q4FY18 and FY18 financial results will be held on Wednesday, 30th May, 2018 at 5.00 P.M. Please find attached herewith the conference call details. Kindly take note of the same.
23-05-2018
Bigul

Board to consider Final Dividend

Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2018, inter alia:1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2018; and2. To consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2018.
22-05-2018
Bigul

Board to consider Final Dividend

Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 30, 2018, inter alia:1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2018; and2. To consider and recommend Final Dividend, if any, for the Financial Year ended March 31, 2018.
22-05-2018
Bigul

Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited ('Company')

Notice is hereby given to the Stock Exchanges under Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 30th May, 2018, inter alia, (i) to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2018; and...
22-05-2018
Bigul

Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2018.

In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the half year ended 31st March, 2018. Kindly take the same on record.
11-04-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended March 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Manish NarangDesignation :- Company Secretary and Compliance Officer
06-04-2018
Bigul

Shareholding for the Period Ended March 31, 2018

Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
06-04-2018
Next Page
Close

Let's Open Free Demat Account